Effects of mistletoe products on pharmacokinetic drug turnover by inhibition and induction of cytochrome P450 activities
Abstract Background European mistletoe (Viscum album) products used in cancer therapy are frequently combined with other anti-cancer-drugs. Hence, potential herb-drug interactions have become a major safety concern in mistletoe therapy. Methods Three European mistletoe products (Helixor® A, Helixor®...
Main Authors: | Michael Schink, Oliver Dehus |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | BMC Complementary and Alternative Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12906-017-2028-1 |
Similar Items
-
The most significant parasitic and saprophytic fungi on common mistletoe (Viscum album L) and their potential application in biocontrol
by: Karadžić Dragan, et al.
Published: (2004-01-01) -
Effect of mistletoe extract on tumor response in neoadjuvant chemoradiotherapy for rectal cancer: a cohort study
by: Jeong-Heum Baek, et al.
Published: (2021-06-01) -
Absence of herb-drug interactions of mistletoe with the tamoxifen metabolite (E/Z)-endoxifen and cytochrome P450 3A4/5 and 2D6 in vitro
by: U. Weissenstein, et al.
Published: (2019-01-01) -
Evaluation of European mistletoe (Viscum album L.) infection in the Castle Park in Lednice
by: Tivadar Baltazár, et al.
Published: (2013-01-01) -
The incidence and distribution of white mistletoe(Viscum albumssp. abietis) on Silver fir (Abies alba Mill.) stands from Eastern Carpathians
by: Cătălina Barbu
Published: (2010-06-01)